vs

Side-by-side financial comparison of Installed Building Products, Inc. (IBP) and PHIBRO ANIMAL HEALTH CORP (PAHC). Click either name above to swap in a different company.

Installed Building Products, Inc. is the larger business by last-quarter revenue ($747.5M vs $373.9M, roughly 2.0× PHIBRO ANIMAL HEALTH CORP). Installed Building Products, Inc. runs the higher net margin — 10.2% vs 7.3%, a 2.9% gap on every dollar of revenue. On growth, PHIBRO ANIMAL HEALTH CORP posted the faster year-over-year revenue change (20.9% vs -0.4%). Installed Building Products, Inc. produced more free cash flow last quarter ($49.3M vs $8.3M). Over the past eight quarters, PHIBRO ANIMAL HEALTH CORP's revenue compounded faster (19.2% CAGR vs 3.9%).

Installed Building Products, Inc. is a leading US-based provider of professional installation services for building products. Core offerings include insulation, gutters, garage doors, fire protection systems and window treatments, serving residential new construction, repair & remodel, and commercial construction segments across most US regions.

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated ...

IBP vs PAHC — Head-to-Head

Bigger by revenue
IBP
IBP
2.0× larger
IBP
$747.5M
$373.9M
PAHC
Growing faster (revenue YoY)
PAHC
PAHC
+21.3% gap
PAHC
20.9%
-0.4%
IBP
Higher net margin
IBP
IBP
2.9% more per $
IBP
10.2%
7.3%
PAHC
More free cash flow
IBP
IBP
$41.0M more FCF
IBP
$49.3M
$8.3M
PAHC
Faster 2-yr revenue CAGR
PAHC
PAHC
Annualised
PAHC
19.2%
3.9%
IBP

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IBP
IBP
PAHC
PAHC
Revenue
$747.5M
$373.9M
Net Profit
$76.6M
$27.5M
Gross Margin
35.0%
35.5%
Operating Margin
14.6%
13.5%
Net Margin
10.2%
7.3%
Revenue YoY
-0.4%
20.9%
Net Profit YoY
14.5%
762.1%
EPS (diluted)
$2.81
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IBP
IBP
PAHC
PAHC
Q4 25
$747.5M
$373.9M
Q3 25
$778.2M
$363.9M
Q2 25
$760.3M
$378.7M
Q1 25
$684.8M
$347.8M
Q4 24
$750.2M
$309.3M
Q3 24
$760.6M
$260.4M
Q2 24
$737.6M
$273.2M
Q1 24
$692.9M
$263.2M
Net Profit
IBP
IBP
PAHC
PAHC
Q4 25
$76.6M
$27.5M
Q3 25
$74.4M
$26.5M
Q2 25
$69.0M
$17.2M
Q1 25
$45.4M
$20.9M
Q4 24
$66.9M
$3.2M
Q3 24
$68.6M
$7.0M
Q2 24
$65.2M
$752.0K
Q1 24
$55.9M
$8.4M
Gross Margin
IBP
IBP
PAHC
PAHC
Q4 25
35.0%
35.5%
Q3 25
34.0%
32.9%
Q2 25
34.2%
29.0%
Q1 25
32.7%
30.1%
Q4 24
33.6%
32.9%
Q3 24
33.8%
32.1%
Q2 24
34.1%
31.9%
Q1 24
33.8%
30.2%
Operating Margin
IBP
IBP
PAHC
PAHC
Q4 25
14.6%
13.5%
Q3 25
13.7%
14.1%
Q2 25
13.3%
8.9%
Q1 25
10.2%
9.6%
Q4 24
13.1%
8.3%
Q3 24
13.3%
6.8%
Q2 24
12.9%
6.7%
Q1 24
12.7%
7.6%
Net Margin
IBP
IBP
PAHC
PAHC
Q4 25
10.2%
7.3%
Q3 25
9.6%
7.3%
Q2 25
9.1%
4.5%
Q1 25
6.6%
6.0%
Q4 24
8.9%
1.0%
Q3 24
9.0%
2.7%
Q2 24
8.8%
0.3%
Q1 24
8.1%
3.2%
EPS (diluted)
IBP
IBP
PAHC
PAHC
Q4 25
$2.81
$0.67
Q3 25
$2.74
$0.65
Q2 25
$2.52
$0.43
Q1 25
$1.64
$0.51
Q4 24
$2.39
$0.08
Q3 24
$2.44
$0.17
Q2 24
$2.30
$0.02
Q1 24
$1.97
$0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IBP
IBP
PAHC
PAHC
Cash + ST InvestmentsLiquidity on hand
$321.9M
$74.5M
Total DebtLower is stronger
$886.6M
$624.2M
Stockholders' EquityBook value
$709.9M
$332.4M
Total Assets
$2.1B
$1.4B
Debt / EquityLower = less leverage
1.25×
1.88×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IBP
IBP
PAHC
PAHC
Q4 25
$321.9M
$74.5M
Q3 25
$333.3M
$85.3M
Q2 25
$305.2M
$77.0M
Q1 25
$298.7M
$70.4M
Q4 24
$327.6M
$67.1M
Q3 24
$406.2M
$89.8M
Q2 24
$380.3M
$114.6M
Q1 24
$399.9M
$98.7M
Total Debt
IBP
IBP
PAHC
PAHC
Q4 25
$886.6M
$624.2M
Q3 25
$880.8M
$628.0M
Q2 25
$876.1M
$631.7M
Q1 25
$872.4M
$635.4M
Q4 24
$874.8M
$639.1M
Q3 24
$872.3M
$295.2M
Q2 24
$875.8M
$312.1M
Q1 24
$875.0M
Stockholders' Equity
IBP
IBP
PAHC
PAHC
Q4 25
$709.9M
$332.4M
Q3 25
$678.6M
$311.7M
Q2 25
$664.5M
$285.7M
Q1 25
$660.9M
$266.0M
Q4 24
$705.3M
$246.8M
Q3 24
$716.4M
$258.5M
Q2 24
$685.3M
$256.6M
Q1 24
$679.2M
$270.1M
Total Assets
IBP
IBP
PAHC
PAHC
Q4 25
$2.1B
$1.4B
Q3 25
$2.1B
$1.4B
Q2 25
$2.0B
$1.4B
Q1 25
$2.0B
$1.3B
Q4 24
$2.1B
$1.3B
Q3 24
$2.1B
$966.3M
Q2 24
$2.0B
$982.2M
Q1 24
$2.0B
$979.0M
Debt / Equity
IBP
IBP
PAHC
PAHC
Q4 25
1.25×
1.88×
Q3 25
1.30×
2.01×
Q2 25
1.32×
2.21×
Q1 25
1.32×
2.39×
Q4 24
1.24×
2.59×
Q3 24
1.22×
1.14×
Q2 24
1.28×
1.22×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IBP
IBP
PAHC
PAHC
Operating Cash FlowLast quarter
$64.9M
$19.4M
Free Cash FlowOCF − Capex
$49.3M
$8.3M
FCF MarginFCF / Revenue
6.6%
2.2%
Capex IntensityCapex / Revenue
2.1%
3.0%
Cash ConversionOCF / Net Profit
0.85×
0.70×
TTM Free Cash FlowTrailing 4 quarters
$300.8M
$47.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IBP
IBP
PAHC
PAHC
Q4 25
$64.9M
$19.4M
Q3 25
$124.0M
$9.3M
Q2 25
$90.4M
$21.3M
Q1 25
$92.1M
$43.2M
Q4 24
$74.8M
$3.1M
Q3 24
$101.4M
$12.6M
Q2 24
$79.0M
$28.4M
Q1 24
$84.8M
$11.4M
Free Cash Flow
IBP
IBP
PAHC
PAHC
Q4 25
$49.3M
$8.3M
Q3 25
$104.8M
$-4.5M
Q2 25
$74.8M
$8.1M
Q1 25
$71.9M
$35.4M
Q4 24
$52.9M
$-4.7M
Q3 24
$77.3M
$3.0M
Q2 24
$58.2M
$15.4M
Q1 24
$63.0M
$1.7M
FCF Margin
IBP
IBP
PAHC
PAHC
Q4 25
6.6%
2.2%
Q3 25
13.5%
-1.2%
Q2 25
9.8%
2.1%
Q1 25
10.5%
10.2%
Q4 24
7.1%
-1.5%
Q3 24
10.2%
1.2%
Q2 24
7.9%
5.6%
Q1 24
9.1%
0.6%
Capex Intensity
IBP
IBP
PAHC
PAHC
Q4 25
2.1%
3.0%
Q3 25
2.5%
3.8%
Q2 25
2.1%
3.5%
Q1 25
2.9%
2.2%
Q4 24
2.9%
2.5%
Q3 24
3.2%
3.7%
Q2 24
2.8%
4.8%
Q1 24
3.1%
3.7%
Cash Conversion
IBP
IBP
PAHC
PAHC
Q4 25
0.85×
0.70×
Q3 25
1.67×
0.35×
Q2 25
1.31×
1.24×
Q1 25
2.03×
2.07×
Q4 24
1.12×
0.97×
Q3 24
1.48×
1.81×
Q2 24
1.21×
37.80×
Q1 24
1.52×
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IBP
IBP

Residential New Construction$488.6M65%
Other Customer Installation$67.8M9%
Shower Doors Shelving And Mirrors$53.5M7%
Other Building Products$47.7M6%
Fireproofing And Firestopping$37.6M5%
Rain Gutters$31.3M4%
Window Blinds$18.0M2%
Related Party$6.7M1%

PAHC
PAHC

Medicated Feed Additives And Others$202.1M54%
Mineral Nutrition$68.9M18%
Nutritional Specialties$50.2M13%
Vaccines$37.6M10%
Performance Products$15.0M4%

Related Comparisons